COVID-19 continues to spread throughout the world and affect our communities. During this time, FMD K&L has taken measures to ensure the safety of our workforce while maintaining our commitment to our Valued Customers. FMD K&L continues to monitor the situation on a daily basis, taking guidance from the World Health Organization and the Centers for Disease Control and Prevention.
Click links below for detailed information about our response to Covid-19:
The state of our business:
- FMD K&L has the necessary Business Continuity Plans (BCP) and measures put in place to ensure business continuity and to minimize any impact for its customers.
- For the time being, FMD K&L has transitioned into a virtual, work from home workforce. This transition has been seamless and our Clients will not experience delays in deliverables.
- All departments continue to function virtually, meeting on a regular basis through video conferencing software.
- A new Task Force was formed to evaluate the impact of COVID-19 to all clinical trials and to partner with our customers to work on any challenges in meeting the regulatory requirements.
Due to our global presence, experience and systems, we are well prepared to handle unforeseen events and adapt where necessary. We understand our commitment to our customers’ deliverables and timelines is of paramount importance, and we look forward to serving their needs in the face of adversity.